Methyldopa hydrate
APICAS: 41372-08-1
Sample Stock:
Methyldopa hydrate is a centrally acting antihypertensive active pharmaceutical ingredient. It lowers blood pressure by inhibiting sympathetic nervous activity and is mainly used for the treatment of hypertension, particularly in pregnancy-induced hypertension. It has a favorable safety profile and extensive clinical use, and is commonly formulated into oral dosage forms such as tablets.
Related Information
Purity:99%+
Registration:GMP/DMF
Biological Profile
Biological Targets
ADRA2A·ADRA2C·ADRA2B
Associated Conditions
preeclampsia·hypertension·type 1 diabetes mellitus
Key Intermediates
2 Items| Structure | Name | CAS No. | Sample Stock | MDL No. | Details |
|---|---|---|---|---|---|
 | Methyldopa | 555-30-6 | MFCD00004186 | ||
 | Veratraldehyde | 120-14-9 | MFCD00003363 |